Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
Ricin Vaccine Featured at Rare Diseases and Orphan Products Summit Medical Countermeasures October 12, 2016 …
DoD to Study Omadacycline as Countermeasure for Plague, Anthrax Contracts + Grants October 12, 2016 …
Wyss Institute Unveils Portable, Low-Cost Biomolecular Manufacturing Biodetection September 26, 2016 …
Phase I Study Planned for Multivalent Vaccine to Combat Ebola, Marburg Industry News September 12, 2016 …
